Stents

This channel includes news and new technology innovations for stents, also called vascular scaffolds. Stents are used to help prop open a vessel treated by balloon angioplasty because of the barotrauma caused by the extreme stretching of vessel walls. The stent enables to vessel to heal in an open position with collapsing. Drug eluting stents (DES) are coated in anti-proliferative drugs to precent scar tissue growth which can cause restenosis and occlude the vessel. DES require antiplatelet therapy because the drug carrier polymer on DES can cause thrombus inside the stent, even years after treatment, which is why bare metal stents are still used in some patients. This page includes news on coronary stents, carotid stents, peripheral stents, bioresorbable stents, and renal stents. 

News

July 30, 2014 — OrbusNeich announced the first patient has been enrolled in the Multinational Abluminal Sirolimus Coated ...

Home July 30, 2014
Home
Technology

July 22, 2014 — Boston Scientific announced it received U.S. Food and Drug Administration (FDA) approval for the Rebel ...

Home July 22, 2014
Home
News
July 21, 2014 – Stentys announced the publication of an article in the Journal of the American College of Cardiology ...
Home July 21, 2014
Home
News

July 15, 2014 — Micell Technologies Inc. announced the United States Patent and Trademark Office (USPTO) has issued a ...

Home July 15, 2014
Home
News

July 10, 2014 — 480 Biomedical announced it has been awarded Phase II funding from the National Heart, Lung, and Blood ...

Home July 10, 2014
Home
Blog | Cardiovascular Business

A big fly in the ointment for widespread adoption of many new technologies is cost. In today’s cost-conscience ...

Home July 09, 2014
Home
Feature

A big fly in the ointment for widespread adoption of many new technologies is cost. In today’s cost-conscience ...

Home July 09, 2014
Home
News

June 24, 2014 — OrbusNeich announced the completion of enrollment in the prospective, multicenter, all-comers REMEDEE ...

Home June 24, 2014
Home
Feature
June 16, 2014 — Medtronic announced it is purchasing Covidien in a cash-and-stock deal for $42.9 billion. Once the ...
Home June 16, 2014
Home
News

June 10, 2014 — Ariad Pharmaceuticals Inc. and Medinol Ltd. earlier this year initiated two registration trials of ...

Home June 10, 2014
Home
Feature

June 3, 2014 — Strokes kill nearly 130,000 Americans every year, according to the Centers for Disease Control and ...

Home June 03, 2014
Home
News

May 23, 2014 — Stentys presented final results from the APPOSITION IV study of its new self-apposing sirolimus-eluting ...

Home May 23, 2014
Home
Elixir Medical Corp. DESolve 100 CE mark
Feature

May 13, 2014 — Elixir Medical Corp. received European CE mark approval for its DESolve 100 Novolimus-eluting Bioresorbab ...

Home May 13, 2014
Home
News

May 9, 2014 — InspireMD Inc. initiated a Voluntary Field Action (VFA) following recent reports of MGuard Prime EPS ...

Home May 09, 2014
Home
News

May 1, 2014 — Boston Scientific Corp. has launched the Promus Premier Everolimus-Eluting Platinum Chromium Coronary ...

Home May 01, 2014
Home
Subscribe Now